Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
101.88
-2.11 (-2.03%)
At close: Mar 30, 2026, 4:00 PM EDT
102.72
+0.84 (0.82%)
Pre-market: Mar 31, 2026, 8:56 AM EDT
Abbott Laboratories (ABT) Revenue by Segment
History
| Date | Medical Devices | Diagnostics | Nutrition | Established Pharmaceuticals | Other |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21.39B | 8.94B | 8.45B | 5.54B | 17.00M |
| Sep 30, 2025 | 20.76B | 9.00B | 8.64B | 5.42B | 17.00M |
| Jun 30, 2025 | 20.06B | 9.16B | 8.55B | 5.32B | 17.00M |
| Mar 31, 2025 | 19.43B | 9.18B | 8.49B | 5.23B | 16.00M |
| Dec 31, 2024 | 18.99B | 9.34B | 8.41B | 5.19B | 16.00M |
| Sep 30, 2024 | 18.38B | 9.36B | 8.32B | 5.15B | 15.00M |
| Jun 30, 2024 | 17.88B | 9.39B | 8.33B | 5.11B | 15.00M |
| Mar 31, 2024 | 17.44B | 9.51B | 8.26B | 5.10B | 14.00M |
| Dec 31, 2023 | 16.89B | 9.99B | 8.15B | 5.07B | 14.00M |
| Sep 30, 2023 | 16.19B | 10.76B | 7.93B | 5.06B | 13.00M |
| Jun 30, 2023 | 15.56B | 11.98B | 7.66B | 5.02B | 12.00M |
| Mar 31, 2023 | 15.02B | 13.99B | 7.53B | 4.95B | 11.00M |
| Dec 31, 2022 | 14.69B | 16.58B | 7.46B | 4.91B | 11.00M |
| Sep 30, 2022 | 14.69B | 17.75B | 7.68B | 4.90B | 11.00M |
| Jun 30, 2022 | 14.70B | 17.99B | 8.00B | 4.84B | 19.00M |
| Mar 31, 2022 | 14.61B | 16.92B | 8.15B | 4.80B | 39.00M |
| Dec 31, 2021 | 14.37B | 15.64B | 8.29B | 4.72B | 52.00M |
| Sep 30, 2021 | 13.88B | 15.52B | 8.19B | 4.66B | 65.00M |
| Jun 30, 2021 | 13.41B | 14.25B | 8.00B | 4.50B | 74.00M |
| Mar 31, 2021 | 12.17B | 12.99B | 7.78B | 4.33B | 67.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.